No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Monday, October 6, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Startups

Amsterdam’s Avidicure exits stealth mode with €43.8M to develop new antibody therapies

by TheAdviserMagazine
5 months ago
in Startups
Reading Time: 2 mins read
A A
Amsterdam’s Avidicure exits stealth mode with €43.8M to develop new antibody therapies
Share on FacebookShare on TwitterShare on LInkedIn


Based out of Amsterdam,  Avidicure, a biotechnology company, announced its launch with $50M (approximately €43.8M) in a seed financing round led by EQT Life Sciences.

Additional investors, including Kurma Partners, BioGeneration Ventures, BOM, Curie Capital, and V-Bio Ventures,  also participated in the round.

Avidicure: Developing multifunctional antibody modality to treat cancer

Led by Arthur Lahr, Avidicure is developing dual agonistic, multifunctional, and avidity-engineered antibodies, “AVC-Boosters”, that can safely deliver targeted and potent cancer monotherapy.

The AVC-Booster design surpasses the best qualities of first-generation antibodies, checkpoint inhibitors, T-cell engagers, and antibody-drug conjugates (ADCs). 

“AVC-Boosters have the potential to change the treatment landscape for a wide range of cancers as first-in-class multifunctional antibody products that safely mobilize the full power of the immune system,” says Arthur Lahr, Chief Executive Officer of Avidicure.

“Our products drive targeted and potent immune responses only in the tumor with reduced toxicity risk. We are eager to build a broad pipeline with our unique platform and progress our lead oncology product, AVC-S-101, into clinical development for solid tumors,” adds Lahr.

With the AVC-Booster plug-and-play functionality, multiple products can be developed, claims the company.  

Avidicure’s lead product, AVC-S-101, is a TROP2-targeting booster that is being developed for non-small cell lung cancer and multiple other indications. 

“Avidicure is taking an entirely new approach with broad clinical potential,” says Dr. Joern-Peter Halle, former Chief Strategy Officer and Global Head of Research at Merck KGaA and Chairman of Avidicure’s Scientific Advisory Board.

“Avidicure’s multifunctional antibodies provide a novel treatment modality with a unique, differentiated mode of action. These products are well-positioned to make a significant impact in the treatment of cancer patients,” adds Halle.

The company plans to present its preclinical data at the upcoming American Association for Cancer Research (AACR) Annual Meeting in April and at the American Society of Clinical Oncology (ASCO) Annual Meeting in May.

Founding management team 

The company’s founding management team consists of Arthur Lahr (CEO), Dirk De Naeyer (COO), Robert Friesen (CSO), and Govert Schouten (CBO), who previously served as executive management in Crucell, Ablynx, and Kiadis, and played key roles in the acquisitions of these successful European biotech companies.

The Supervisory Board includes industry veterans Frank Verwiel (Intellia, Aptalis, Bavarian Nordic, Merck & Co.), Martijn Kleijwegt (EQT-LS), Hunter Smith (Rhythm), and Helen Collins (Five Prime, Enliven, Gilead, Amgen).



Source link

Tags: 43.8MAmsterdamsantibodyAvidicuredevelopExitsmodeStealthTherapies
ShareTweetShare
Previous Post

Consumers are so stressed by the economy they’re doing less laundry to save on detergent

Next Post

Hot Stocks KW 17/2025: Die stärksten Aktien nach dem Zoll-Crash!

Related Posts

edit post
Driversnote logs new milestone in its bootstrapped journey, picks up VIA equity as co-owner

Driversnote logs new milestone in its bootstrapped journey, picks up VIA equity as co-owner

by TheAdviserMagazine
October 6, 2025
0

Copenhagen-based Driversnote, a company specialised in mobile mileage tracking and reporting, announced that it has entered a strategic partnership with...

edit post
The Weekly Notable Startup Funding Report: 10/6/25 – AlleyWatch

The Weekly Notable Startup Funding Report: 10/6/25 – AlleyWatch

by TheAdviserMagazine
October 6, 2025
0

The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of...

edit post
Heidi Health raises M Series B led by Steve Cohen’s Point72

Heidi Health raises $65M Series B led by Steve Cohen’s Point72

by TheAdviserMagazine
October 6, 2025
0

Dr. Tom Kelly is a trauma surgeon, and everywhere, he sees doctors drowning in administrative work. He wanted change, so...

edit post
OpenAI and Jony Ive may be struggling to figure out their AI device

OpenAI and Jony Ive may be struggling to figure out their AI device

by TheAdviserMagazine
October 5, 2025
0

OpenAI and Jony Ive face significant technical challenges as they work to develop a screen-less, AI-powered device, according to the...

edit post
Gen Z Hiring Trends You Can’t Afford to Ignore

Gen Z Hiring Trends You Can’t Afford to Ignore

by TheAdviserMagazine
October 5, 2025
0

Gen Z is officially entering the workforce. The generation famously known for reshaping consumer markets with TikTok trends is now...

edit post
Startups and the U.S. government: It’s getting complicated

Startups and the U.S. government: It’s getting complicated

by TheAdviserMagazine
October 4, 2025
0

The tie between startups and the U.S. government have strengthened in recent years, a shift buoyed by an interest in...

Next Post
edit post
Hot Stocks KW 17/2025: Die stärksten Aktien nach dem Zoll-Crash!

Hot Stocks KW 17/2025: Die stärksten Aktien nach dem Zoll-Crash!

edit post
Trump’s WLFI crypto investments aren’t paying off

Trump’s WLFI crypto investments aren’t paying off

  • Trending
  • Comments
  • Latest
edit post
What Happens If a Spouse Dies Without a Will in North Carolina?

What Happens If a Spouse Dies Without a Will in North Carolina?

September 14, 2025
edit post
California May Reimplement Mask Mandates

California May Reimplement Mask Mandates

September 5, 2025
edit post
Does a Will Need to Be Notarized in North Carolina?

Does a Will Need to Be Notarized in North Carolina?

September 8, 2025
edit post
DACA recipients no longer eligible for Marketplace health insurance and subsidies

DACA recipients no longer eligible for Marketplace health insurance and subsidies

September 11, 2025
edit post
‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

September 9, 2025
edit post
Tips to Apply for Mental Health SSDI Without Therapy

Tips to Apply for Mental Health SSDI Without Therapy

September 19, 2025
edit post
Riding Strong Among the Dividend Champions

Riding Strong Among the Dividend Champions

0
edit post
Now Accepting Applications: Theory Development Workshop at Oklahoma State University (with Per Bylund)

Now Accepting Applications: Theory Development Workshop at Oklahoma State University (with Per Bylund)

0
edit post
CZ Post Sends 4 Token Soaring As Trader Turns K Into M

CZ Post Sends 4 Token Soaring As Trader Turns $3K Into $2M

0
edit post
The One Legal Document That Should Be Updated Every 5 Years After Sixty

The One Legal Document That Should Be Updated Every 5 Years After Sixty

0
edit post
Central banks keep buying yellow metal despite soaring price

Central banks keep buying yellow metal despite soaring price

0
edit post
Healthy Aging Month: Aging With Dignity Takes a Village

Healthy Aging Month: Aging With Dignity Takes a Village

0
edit post
Central banks keep buying yellow metal despite soaring price

Central banks keep buying yellow metal despite soaring price

October 6, 2025
edit post
How a 2020 dinner in Davos set the stage for a ‘MAGA’ World Cup

How a 2020 dinner in Davos set the stage for a ‘MAGA’ World Cup

October 6, 2025
edit post
How This Investor is Improving Their Hometown One Rehab at a Time

How This Investor is Improving Their Hometown One Rehab at a Time

October 6, 2025
edit post
GE Vernova – GEV: UBS mit „Buy“ & Kursziel 760 USD!

GE Vernova – GEV: UBS mit „Buy“ & Kursziel 760 USD!

October 6, 2025
edit post
ADVISE AI: Get ahead of the curve on AI innovation

ADVISE AI: Get ahead of the curve on AI innovation

October 6, 2025
edit post
AI is becoming the ‘magic fix’ as America places ‘one big bet’ on it not being a bubble, market veteran warns 

AI is becoming the ‘magic fix’ as America places ‘one big bet’ on it not being a bubble, market veteran warns 

October 6, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Central banks keep buying yellow metal despite soaring price
  • How a 2020 dinner in Davos set the stage for a ‘MAGA’ World Cup
  • How This Investor is Improving Their Hometown One Rehab at a Time
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.